(Q95420262)
Statements
Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors (English)
Øyvind S Bruland
Ada Repetto-Llamazares
Nasir Abbas
Jostein Dahle
No description defined
No description defined